Fatty Acid and Lipotoxicity in Obesity and Diabetes

Metabolic diseases such as obesity, diabetes and hypertension are among the most common chronic illnesses and major causes of morbidity worldwide. These diseases are due to alterations of basic metabolic pathways such as those for glucose and lipids, and they are extremely costly to treat. Because of their
increasing prevalence they have attracted tremendous attention from the scientific community in recent years and significant advances have been made in our understanding of their molecular nature.
The potential lipotoxic effect of accumulation of fatty acids in non–adipose issue is thought to be a major component in the development of insulin resistance.
Chronic exposure to elevated free fatty acids affects pancreatic ß cell function, insulin secretion and lipid synthesis in the liver, and storage in adipose tissue.
Maintaining the normal levels of fatty acids requires coordinated regulation between the liver, adipose tissue and skeletal muscle.
This book presents an integrated approach to the problems of obesity and type 2 diabetes and carefully examines the role that fatty acids and lipids play in the development and progression of these diseases and in the transition from one to the other. Topics covered include lipid metabolism, adipose tissue biology, ß cell function and insulin resistance. Specific chapters also deal with the molecular genetics and molecular physiology of energy homeostasis. Fatty Acids and Lipotoxicity in Obesity and Diabetes will be of interest to anyone working on the causes of obesity and diabetes.

Spis treści:
Symposium on Fatty acids and lipotoxicity in obesity and diabetes, held at Tsinghua University, Beijing, China, 17–19 October 2006.
Editors: Gregory Bock (Organizer) and Jamie Goode.
This symposium is based on a proposal made by Peng Li.
Bruce M. Spiegelman – Chair’s introduction.
Bruce M. Spiegelman &# 8211; Transcriptional control of energy homeostasis through the PGC1 coactivators.
Discussion.
Stephen O’Rahilly –  Human obesity and insulin resistance: lessons from experiments of nature.
Discussion.
Deborah M. Muoio and Timothy R. Koves – Lipid–induced metabolic dysfunction in skeletal muscle.
Discussion.
Alan D. Attie, Matthew T. Flowers, Jessica B. Flowers, Albert K. Groen, Folkert Kuipers and James M. Ntambi – Stearoyl–CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Discussion.
Karen Reue – The role of lipin 1 in adipogenesis and lipid metabolism. Discussion.
David Carling – The role of the AMP–activated protein kinase in the regulation of energy homeostasis.
Discussion.
Gökhan S. Hotamisligil – Endoplasmic reticulum stress and inflammation in obesity and type 2 diabetes.
Discussion.
Ira Tabas, Tracie Seimon, Jerry Arellano, Yankun Li, Fabien Forcheron, Dongying Cui, Seongah Han, Chien–Ping Liang, Alan Tall and Domenico Accili – The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis.
Discussion.
Sandra Lobo and David A. Bernlohr – Fatty acid transport in adipocytes and the development of insulin resistance.
Discussion.
Paul N. Black and Concetta C. DiRusso – Vectorial acylation: linking fatty acid transport and activation to metabolic trafficking.
Discussion. 
Günther Daum, Andrea Wagner, Tibor Czabany, Karlheinz Grillitsch and Karin Athenstaedt – Lipid storage and mobilization pathways in yeast.
Discussion. 
John Zhong Li and Peng Li – Cide proteins and the development of obesity.  Discussion.
General discussion I.
Visualizing brown adipose tissue with FDG–PET.
Takashi Kadowaki, Toshimasa Yamauchi, Naoto Kubota, Kazuo Hara and Kohjiro Ueki – Adiponectin and adiponectin recept ors in obesity–linked insulin resistance.
Discussion.
Gabriel Pascual, Amy L. Sullivan, Sumito Ogawa, Amir Gamliel, Valentina Perissi, Michael G. Rosenfeld and Christopher K. Glass –Anti–inflammatory and antidiabetic roles of PPARγ.
Discussion.
Final discussion.
Nutrition, ageing and lipotoxicity.
Index of contributors.
Subject index.

Nota biograficzna:
The Novartis Foundation is an international scientific and educational charity, which promotes the study and general knowledge of science and in particular encourages international co–operation in scientific research.
Chairman: Bruce Spiegelman.

Okładka tylna:
Metabolic diseases such as obesity, diabetes and hypertension are among the most common chronic illnesses and major causes of morbidity worldwide. These diseases are due to alterations of basic metabolic pathways such as those for glucose and lipids, and they are extremely costly to treat. Because of their
increasing prevalence they have attracted tremendous attention from the scientific community in recent years and significant advances have been made in our understanding of their molecular nature.
The potential lipotoxic effect of accumulation of fatty acids in non–adipose issue is thought to be a major component in the development of insulin resistance.
Chronic exposure to elevated free fatty acids affects pancreatic ß cell function, insulin secretion and lipid synthesis in the liver, and storage in adipose tissue.
Maintaining the normal levels of fatty acids requires coordinated regulation between the liver, adipose tissue and skeletal muscle.
This book presents an integrated approach to the problems of obesity and type 2 diabetes and carefully examines the role that fatty acids and lipids play in the development and progression of these diseases and in the transition from one to the other. Topi cs covered include lipid metabolism, adipose tissue biology, ß cell function and insulin resistance. Specific chapters also deal with the molecular genetics and molecular physiology of energy homeostasis. Fatty Acids and Lipotoxicity in Obesity and Diabetes will be of interest to anyone working on the causes of obesity and diabetes.